Inventor · disambiguated record
Ole Petter Veiby
Also filed as: VEIBY OLE PETTER
9 granted patents·7 pending applications·170 citations·filing 2002–2025
88Inventor score
Top patents by PatentIndex Score
16 records- 0196US7494775B2Compositions, kits, and methods for identification, assessment, prevention and therapy of breast and ovarian cancerMILLENNIUM PHARM INC·Filed 2005·Granted Feb 24, 2009·59 cites·9 claims
- 0295US8323906B2Compositions, kits, and methods for identification, assessment, prevention and therapy of breast and ovarian cancerVEIBY OLE PETTER·Filed 2008·Granted Dec 4, 2012·73 cites·14 claims
- 0393US8759490B2Antibodies that bind OV064 and methods of use thereforMILLENNIUM PHARM INC·Filed 2012·Granted Jun 24, 2014·13 cites·12 claims
- 0492US9926378B2Antibodies that bind OV064 and methods of use thereforMILLENNIUM PHARM INC·Filed 2016·Granted Mar 27, 2018·5 cites·18 claims
- 0587US9421277B2Antibodies that bind OV064 and methods of use thereforMILLENNIUM PHARM INC·Filed 2014·Granted Aug 23, 2016·5 cites·12 claims
- 0686US8323645B2Antibodies that bind OV064 and methods of use thereforVEIBY OLE PETTER·Filed 2006·Granted Dec 4, 2012·13 cites·9 claims
- 0780US10533227B2Compositions, kits, and methods for identification, assessment, prevention and therapy of breast and ovarian cancerMILLENNIUM PHARM INC·Filed 2015·Granted Jan 14, 2020·2 cites·24 claims
- 0858US2009286823A1CCR1 Inhibitors useful for the treatment of multiple myeloma and other disordersMILLENNIUM PHARM INC·Filed 2008·Application pending·0 cites
- 0958US2013102482A1Compositions, kits, and methods for identification, assessment, prevention and therapy of breast and ovarian cancerMILLENNIUM PHARM INC·Filed 2012·Application pending·0 cites
- 1051US2003068636A1Compositions, kits and methods for identification, assessment, prevention, and therapy of breast and ovarian cancerMILLENNIUM PHARM INC·Filed 2002·Application pending·0 cites
- 1147US12509510B2IL31-binding polypeptides and uses thereofATTOVIA THERAPEUTICS INC·Filed 2025·Granted Dec 30, 2025·0 cites·19 claims
- 1246US10335494B2Combination of aurora kinase inhibitors and anti-CD30 antibodiesMILLENNIUM PHARM INC·Filed 2014·Granted Jul 2, 2019·0 cites·11 claims
- 1345US2013040979A1Ccr1 inhibitors useful for the treament of multiple myeloma and other disordersMILLENNIUM PHARM INC·Filed 2012·Application pending·0 cites
- 1444US2014356383A1Administration of an anti-gcc antibody-drug conjugate and a dna damaging agent in the treatment of cancerVEIBY OLE PETTER·Filed 2014·Application pending·0 cites
- 1539US2018271996A1Combination therapies of her2-targeted antibody-drug conjugatesMERSANA THERAPEUTICS INC·Filed 2018·Application pending·0 cites
- 1637US2019038762A1Gcc-targeted antibody-drug conjugatesMILLENNIUM PHARM INC·Filed 2017·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Ole Petter Veiby files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →